ALK-Abelló A/S (LON:0OIR)
223.05
-1.35 (-0.60%)
At close: Dec 12, 2025
ALK-Abelló Revenue
ALK-Abelló had revenue of 1.53B DKK in the quarter ending September 30, 2025, with 16.53% growth. This brings the company's revenue in the last twelve months to 6.08B, up 12.91% year-over-year. In the year 2024, ALK-Abelló had annual revenue of 5.54B with 14.78% growth.
Revenue (ttm)
6.08B DKK
Revenue Growth
+12.91%
P/S Ratio
8.21
Revenue / Employee
2.21M DKK
Employees
2,753
Market Cap
5.83B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.54B | 713.00M | 14.78% |
| Dec 31, 2023 | 4.82B | 313.00M | 6.94% |
| Dec 31, 2022 | 4.51B | 595.00M | 15.19% |
| Dec 31, 2021 | 3.92B | 425.00M | 12.17% |
| Dec 31, 2020 | 3.49B | 217.00M | 6.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |